| ApoA1 | Apolipoprotein A1 |
| B2M | Beta-2 microglobulin |
| CA125 | Cancer Antigen 125 |
| CI | Confidence interval |
| CV | Coefficient of variation |
| ESI | Electrospray ionization |
| FOLR1 | Folate receptor alpha |
| GI | Gastrointestinal |
| GU | Genitourinary |
| HE4 | Human epididymis protein 4 |
| HGSC | High-Grade Serous Carcinoma |
| LC-MS | Liquid chromatography–mass spectrometry |
| ML | Machine Learning |
| MUC1 | Mucin 1 |
| OC | Ovarian Cancer |
| PLCO | Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial |
| SN | Sensitivity |
| SP | Specificity |
| TVUS | Transvaginal ultrasound |
| UKCTOCS | UK Collaborative Trial of Ovarian Cancer Screening |
| USPSTF | U.S. Preventive Services Task Force |
| VAS | Vague Abdominal Symptoms |